FindTrial
Sign In

Studying muscle loss and fear of falling in people with cancer receiving chemotherapy

Screening for sarcopenia and fear of falls in individuals with cancer undergoing chemotherapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108981
Enrollment
133
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Ancilla Blessy Verghese
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Those who are diagnosed with cancer and are currently undergoing at least one cycle of chemotherapy Eastern Cooperative Oncology Group (ECOG) score of less than 3

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sarcopenia (SARC-F score, BIA-derived muscle mass, handgrip strength, Skeletal Mass Index, calf circumference) and fear of falls (FES-I score)Timepoint: Assessed at a single time point (baseline)—

Secondary

MeasureTime frame
Association between sarcopenia and fear of fallsTimepoint: Assessed at single time point (baseline)—

Countries

India

Contacts

Public ContactMrs Nivedita S Prabhu

Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal

arun.maiya@manipal.edu9845350823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026